113 related articles for article (PubMed ID: 27650819)
1. Appropriateness of Acid Suppression Therapy.
De Rijdt T; Spriet I; Willems L; Blanckaert M; Hiele M; Wilmer A; Simoens S
Ann Pharmacother; 2017 Feb; 51(2):125-134. PubMed ID: 27650819
[TBL] [Abstract][Full Text] [Related]
2. Impact of a clinical pharmacist stress ulcer prophylaxis management program on inappropriate use in hospitalized patients.
Buckley MS; Park AS; Anderson CS; Barletta JF; Bikin DS; Gerkin RD; O'Malley CW; Wicks LM; Garcia-Orr R; Kane-Gill SL
Am J Med; 2015 Aug; 128(8):905-13. PubMed ID: 25820164
[TBL] [Abstract][Full Text] [Related]
3. Acid Suppressive Therapy for Stress Ulcer Prophylaxis in Noncritically Ill Patients.
Hong MT; Monye LC; Seifert CF
Ann Pharmacother; 2015 Sep; 49(9):1004-8. PubMed ID: 26139638
[TBL] [Abstract][Full Text] [Related]
4. Overuse of Acid-Suppression Therapy at an Urban Tertiary Hospital.
Redfern RE; Brown M; Karhoff KL; Middleton JL
South Med J; 2015 Dec; 108(12):732-8. PubMed ID: 26630894
[TBL] [Abstract][Full Text] [Related]
5. A Successful Pharmacist-Based Quality Initiative to Reduce Inappropriate Stress Ulcer Prophylaxis Use in an Academic Medical Intensive Care Unit.
Masood U; Sharma A; Bhatti Z; Carroll J; Bhardwaj A; Sivalingam D; Dhamoon AS
Inquiry; 2018; 55():46958018759116. PubMed ID: 29502481
[TBL] [Abstract][Full Text] [Related]
6. Clinical Outcomes of Acid Suppressive Therapy Use in Hematology/Oncology Patients at an Academic Medical Center.
McCaleb RV; Gandhi AS; Clark SM; Clemmons AB
Ann Pharmacother; 2016 Jul; 50(7):541-7. PubMed ID: 27091869
[TBL] [Abstract][Full Text] [Related]
7. The impact of pharmacist interventions on the inappropriate use of acid-suppression therapy.
Hughes GJ; Belgeri MT; Perry HM
Consult Pharm; 2011 Jul; 26(7):485-90. PubMed ID: 21729849
[TBL] [Abstract][Full Text] [Related]
8. The use of proton pump inhibitors in an Italian hospital: focus on oncologic and critical non-ICU patients.
Meli M; Raffa MP; Malta R; Morreale I; Aprea L; D'Alessandro N
Int J Clin Pharm; 2015 Dec; 37(6):1152-61. PubMed ID: 26319396
[TBL] [Abstract][Full Text] [Related]
9. Potential costs of inappropriate use of proton pump inhibitors.
Ladd AM; Panagopoulos G; Cohen J; Mar N; Graham R
Am J Med Sci; 2014 Jun; 347(6):446-51. PubMed ID: 24270078
[TBL] [Abstract][Full Text] [Related]
10. Four-year trends of inappropriate proton pump inhibitor use after hospital discharge.
Leri F; Ayzenberg M; Voyce SJ; Klein A; Hartz L; Smego RA
South Med J; 2013 Apr; 106(4):270-3. PubMed ID: 23558416
[TBL] [Abstract][Full Text] [Related]
11. Impact of A Collaborative Strategy to Reduce the Inappropriate Use of Acid Suppressive Therapy in Non-Intensive Care Unit Patients.
Belfield KD; Kuyumjian AG; Teran R; Amadi M; Blatt M; Bicking K
Ann Pharmacother; 2017 Jul; 51(7):577-583. PubMed ID: 28622739
[TBL] [Abstract][Full Text] [Related]
12. Reasons for initiation of proton pump inhibitor therapy for hospitalised patients and its impact on outpatient prescription in primary care.
Villamañán E; Ruano M; Lara C; Suárez-de-Parga JM; Armada E; Álvarez-Sala R; Pérez E; Herrero A
Rev Esp Enferm Dig; 2015 Nov; 107(11):652-8. PubMed ID: 26541654
[TBL] [Abstract][Full Text] [Related]
13. Impact of a clinical pharmacist-led stewardship program for the appropriate use of acid suppression therapy in older hospitalized patients: a non-randomized controlled study.
Dumlu HI; Sancar M; Ozdemir A; Okuyan B
Int J Clin Pharm; 2022 Aug; 44(4):914-921. PubMed ID: 35449351
[TBL] [Abstract][Full Text] [Related]
14. An economic analysis of inadequate prescription of antiulcer medications for in-hospital patients at a third level institution in Colombia.
Machado-Alba JE; Castrillón-Spitia JD; Londoño-Builes MJ; Fernández-Cardona A; Campo-Betancourth CF; Ochoa-Orozco SA; Echeverri-Cataño LF; Ruiz-Villa JO; Gaviria-Mendoza A
Rev Esp Enferm Dig; 2014 Feb; 106(2):77-85. PubMed ID: 24852732
[TBL] [Abstract][Full Text] [Related]
15. Overuse of acid suppressive therapy in hospitalised patients with pulmonary diseases.
Niklasson A; Bajor A; Bergendal L; Simrén M; Strid H; Björnsson E
Respir Med; 2003 Oct; 97(10):1143-50. PubMed ID: 14561022
[TBL] [Abstract][Full Text] [Related]
16. [Proton bomb inhibitors: a study of the prescription in a functional recovery unit].
López-Dóriga Bonnardeaux P; Neira Álvarez M; Mansilla Laguía S
Rev Esp Geriatr Gerontol; 2013; 48(6):269-71. PubMed ID: 24099902
[TBL] [Abstract][Full Text] [Related]
17. Overuse of acid suppression therapy in hospitalized patients.
Gupta R; Garg P; Kottoor R; Munoz JC; Jamal MM; Lambiase LR; Vega KJ
South Med J; 2010 Mar; 103(3):207-11. PubMed ID: 20134378
[TBL] [Abstract][Full Text] [Related]
18. Clinical Pharmacist-Led Impact on Inappropriate Albumin Utilization and Associated Costs in General Ward Patients.
Buckley MS; Agarwal SK; Lansburg JM; Kopp BJ; Erstad BL
Ann Pharmacother; 2021 Jan; 55(1):44-51. PubMed ID: 32578446
[TBL] [Abstract][Full Text] [Related]
19. Cost-Effectiveness of Histamine
Hammond DA; Kathe N; Shah A; Martin BC
Pharmacotherapy; 2017 Jan; 37(1):43-53. PubMed ID: 27809338
[TBL] [Abstract][Full Text] [Related]
20. Frequency of inappropriate continuation of acid suppressive therapy after discharge in patients who began therapy in the surgical intensive care unit.
Murphy CE; Stevens AM; Ferrentino N; Crookes BA; Hebert JC; Freiburg CB; Rebuck JA
Pharmacotherapy; 2008 Aug; 28(8):968-76. PubMed ID: 18657013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
